Therapeutic Uses of Red Macroalgae.

Area of Science:

• Marine Biology
• Phycology
• Biochemistry

Background:

• Red seaweeds (Rhodophyta) comprise ~7000 species, recognized for diverse bioactive constituents.
• These constituents include proteins, pigments, fatty acids, vitamins, minerals, phenolics, and notably, sulfated polysaccharides.
• Polysaccharides, particularly galactans like carrageenans and agars, are major cell wall components (40-50% dry weight) and are valued for thickening and gelling properties.

Purpose of the Study:

• To review the pharmaceutical applications of red seaweed.
• To explore the exploitation of specific compounds and secondary metabolites from Rhodophyta.
• To highlight the nutritional, medical, and industrial importance of red seaweed bioactives.

Main Methods:

• Literature review focusing on Rhodophyta composition and bioactivities.
• Analysis of chemical constituents and their properties.
• Examination of therapeutic potentials and industrial applications.

Main Results:

• Red seaweeds are a significant source of bioactive compounds with diverse applications.
• Sulfated polysaccharides (carrageenans, agars) exhibit broad-spectrum therapeutic properties.
• Red seaweed compounds show potential in cancer therapy, anti-inflammatory treatments, and acetylcholinesterase inhibition.

Conclusions:

• Red seaweeds represent a valuable, sustainable resource for pharmaceutical and industrial applications.
• Their unique chemical composition, especially polysaccharides, drives their utility.
• Further research into Rhodophyta metabolites can yield novel therapeutic agents and natural ingredients.